# Cannabinoid Clinical Trials: Cannabis Intervention for Teens > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/sequential-cannabis-prevention-messaging-adolescents/ > **Published:** 2026-03-03T21:44:26-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T12:01:10-04:00 > **Clinical Summary:** Explore sequential cannabis prevention messaging adolescents to improve intervention efficacy and reduce cannabis use intentions in at-risk teens. --- #### Clinical Takeaway Tailored cannabis prevention messaging that first addresses and rebuts adolescents’ objections before delivering a targeted follow-up communication shows promise for reaching at-risk youth who resist standard prevention appeals. A sequential, multi-message approach may be more effective than single-message campaigns because it accounts for the diversity of attitudes and social norms among adolescent populations. Standard one-size-fits-all prevention strategies have historically underperformed, and individualized messaging frameworks represent a more clinically sound direction for youth cannabis education. ### #26 A Rebuttal-Based Social Norms-Tailored Cannabis Intervention for At-Risk Adolescents. **Citation:** Donaldson Candice D et al. *A Rebuttal-Based Social Norms-Tailored Cannabis Intervention for At-Risk Adolescents.* Prevention science: the official journal of the Society for Prevention Research. 2021. PMID: 33791930. **Study type:** Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural  |  **Topic area:** Pediatrics  |  **CED Score:** 10 Design: 5 Journal: 0 N: 3 Recency: 0 Pop: 3 Human: 1 Risk: -2 Why This Matters This study addresses a significant clinical gap by demonstrating that tailored, sequential messaging approaches can overcome adolescent resistance to cannabis prevention efforts, potentially improving intervention efficacy in a population with documented high susceptibility to [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) initiation. The rebuttal-based methodology may inform more effective public health messaging strategies and clinical prevention protocols by accounting for individual variation in beliefs and reducing counterargument generation, which typically undermines standard prevention campaigns. For clinicians working with at-risk youth, these findings suggest that personalized approaches addressing specific cognitive barriers could enhance the effectiveness of [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) prevention efforts during a critical developmental window. **Quality Gate Alerts:** - Preclinical only **Abstract:** Many past cannabis prevention campaigns have proven largely ineffective due in part to the diversity of adolescents’ cannabis-relevant beliefs. The current studies evaluated the impact of a sequential multiple message approach tailored to the usage norms of adolescents expressing negative attitudes toward a cannabis prevention appeal. A multiple-message strategy was implemented-initial unfavorable message evaluations were invalidated using attitudinal rebuttal feedback prior to presenting a third tailored communication. Participants were cannabis-abstinent middle and high school students (ages 11 to 16). Study 1 (N = 808) compared effects of gain- and loss-framed messages tailored to each student’s normative usage perceptions. In Study 2 (N = 391), students were randomly assigned to receive a tailored or non-tailored message after receiving feedback meant to destabilize anti-message attitudes. For at-risk adolescents in Study 1 who perceived [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) as normative, a tailored gain-framed message resulted in the lowest usage intentions (p < .05). In Study 2, a conditional multiple-moderated mediation model showed that for high-risk teens with normative beliefs and pro-cannabis attitudes, exposure to a tailored gain-framed communication was associated with decreased cannabis attitude certainty, and lower usage intentions 2 months later (p < .05). Findings have implications for sequential messaging utilization in mass media campaigns and support the efficacy of tailored messages over a one-size-fits-all media approach. Further, results suggest that systematically weakening resistance to persuasive communications and tailoring messages consistent with individually perceived peer norms is an effective prevention strategy. Clinical Perspective This intervention study addresses a genuine gap in adolescent cannabis prevention by recognizing that one-size-fits-all messaging often backfires, particularly among teens who initially resist prevention appeals. The sequential rebuttal approach shows promise for overcoming reactance and shifting cannabis-related social norm perceptions, which are known drivers of adolescent use. However, the study’s effectiveness depends heavily on implementation fidelity, the durability of attitude change beyond the immediate intervention period, and whether lab-based or controlled settings translate to real-world prevention success. Clinicians should recognize that while tailored, evidence-based prevention conversations with adolescent patients and their families may help counter permissive peer norms around cannabis, this intervention cannot replace comprehensive screening, direct counseling about neurodevelopmental risks, and engagement of family systems. In practice, knowledge of these messaging principles can inform how we discuss cannabis with hesitant or skeptical teens—meeting them where their attitudes are rather than repeating ineffective talking points—while maintaining clear clinical guidance on abstin [PubMed](https://pubmed.ncbi.nlm.nih.gov/33791930/)  |  [PMC Full Text](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312490/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoid Clinical Trials: Cannabis Intervention in Teens](https://cedclinic.com/sequential-cannabis-prevention-messaging-teens/) Review [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) focused on cannabis interventions specifically designed for adolescent populations. [Read More](https://cedclinic.com/sequential-cannabis-prevention-messaging-teens/) [Endocannabinoid System Research: Clinical Evidence Review](https://cedclinic.com/endocannabinoid-system-clinical-research-findings-review/) Explore comprehensive clinical evidence on the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) relevant to [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) and interventions. [Explore Now](https://cedclinic.com/endocannabinoid-system-clinical-research-findings-review/) [Cannabinoid Clinical Trials: Cannabis in At-Risk Teens](https://cedclinic.com/sequential-messaging-cannabis-prevention-at-risk-teens/) Investigate [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) addressing cannabis use and prevention strategies in at-risk adolescent groups. [Learn More](https://cedclinic.com/sequential-messaging-cannabis-prevention-at-risk-teens/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Cannabinoid%20Clinical%20Trials%3A%20Cannabis%20Intervention%20for%20Teens&url=https%3A%2F%2Fcedclinic.com%2Fsequential-cannabis-prevention-messaging-adolescents%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fsequential-cannabis-prevention-messaging-adolescents%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Cannabinoid%20Clinical%20Trials%3A%20Cannabis%20Intervention%20for%20Teens%20https%3A%2F%2Fcedclinic.com%2Fsequential-cannabis-prevention-messaging-adolescents%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).